These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21734124)

  • 1. Atypical lesions as a sign of cutaneous dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species.
    Santos-Oliveira JR; Da-Cruz AM; Pires LH; Cupolillo E; Kuhls K; Giacoia-Gripp CB; Oliveira-Neto MP
    Am J Trop Med Hyg; 2011 Jul; 85(1):55-9. PubMed ID: 21734124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.
    Gelanew T; Hurissa Z; Diro E; Kassahun A; Kuhls K; Schönian G; Hailu A
    Am J Trop Med Hyg; 2011 Jun; 84(6):906-12. PubMed ID: 21633027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients.
    Gramiccia M; Gradoni L; Troiani M
    Trans R Soc Trop Med Hyg; 1992; 86(2):161-3. PubMed ID: 1440776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome.
    Hofman V; Marty P; Perrin C; Saint-Paul MC; Le Fichoux Y; Michiels JF; Glaichenhaus N; Pratlong F; Hofman P
    Hum Pathol; 2000 Jan; 31(1):75-84. PubMed ID: 10665917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis.
    Cunha J; Carrillo E; Sánchez C; Cruz I; Moreno J; Cordeiro-da-Silva A
    Parasit Vectors; 2013 Apr; 6():122. PubMed ID: 23622683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leishmania infantum/HIV co-infection: cutaneous lesions following treatment of visceral leishmaniasis].
    Catorze G; Alberto J; Afonso A; Vieira R; Cortes S; Campino L
    Ann Dermatol Venereol; 2006 Jan; 133(1):39-42. PubMed ID: 16495850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis.
    Bosch RJ; Rodrigo AB; Sánchez P; de Gálvez MV; Herrera E
    Int J Dermatol; 2002 Oct; 41(10):670-5. PubMed ID: 12390190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases.
    Agostoni C; Dorigoni N; Malfitano A; Caggese L; Marchetti G; Corona S; Gatti S; Scaglia M
    Infection; 1998; 26(2):93-9. PubMed ID: 9561378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
    Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
    Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.
    Pintado V; Martín-Rabadán P; Rivera ML; Moreno S; Bouza E
    Medicine (Baltimore); 2001 Jan; 80(1):54-73. PubMed ID: 11204503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain.
    Jiménez M; Ferrer-Dufol M; Cañavate C; Gutiérrez-Solar B; Molina R; Laguna F; López-Vélez R; Cercenado E; Daudén E; Blázquez J
    FEMS Microbiol Lett; 1995 Sep; 131(2):197-204. PubMed ID: 7557330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
    Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings.
    Diro E; van Griensven J; Mohammed R; Colebunders R; Asefa M; Hailu A; Lynen L
    Lancet Infect Dis; 2015 Jan; 15(1):122-9. PubMed ID: 25300862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.
    Montalban C; Martinez-Fernandez R; Calleja JL; Garcia-Diaz JD; Rubio R; Dronda F; Moreno S; Yebra M; Barros C; Cobo J
    Rev Infect Dis; 1989; 11(4):655-60. PubMed ID: 2672242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
    Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
    Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: First Coinfection Report of Mixed
    Badirzadeh A; Mohebali M; Sabzevari S; Ghafoori M; Arzamani K; Seyyedin M; Hashemi SA
    Am J Trop Med Hyg; 2018 Jan; 98(1):122-125. PubMed ID: 29165208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1.
    Pizzuto M; Piazza M; Senese D; Scalamogna C; Calattini S; Corsico L; Persico T; Adriani B; Magni C; Guaraldi G; Gaiera G; Ludovisi A; Gramiccia M; Galli M; Moroni M; Corbellino M; Antinori S
    J Clin Microbiol; 2001 Jan; 39(1):357-61. PubMed ID: 11136800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of laryngeal leishmaniasis in patients infected with HIV.
    González-Anglada MI; Peña JM; Barbado FJ; González JJ; Redondo C; Galera C; Nistal M; Vázquez JJ
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):509-11. PubMed ID: 7957275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy.
    Peters BS; Fish D; Golden R; Evans DA; Bryceson AD; Pinching AJ
    Q J Med; 1990 Nov; 77(283):1101-11. PubMed ID: 2274656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.